| Hemangioendothelioma studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT03331250Phase 2 · completed Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07684287Phase 2 · not yet recruiting A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07656909Phase 2/Phase 3 · recruiting Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Kaposiform Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07104331Phase 2 · recruiting SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06408441recruiting The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07477548Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04008238NA · completed Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03967834NA · recruiting Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02625389Phase 4 · completed A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541652recruiting A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers · condition mapped ALIAS · 21 trials mapped (9 active) | — | — | Liver Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03148275Phase 2 · completed Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05228015Phase 1 · terminated Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06452160Phase 1 · recruiting A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05324384Phase 2 · unknown Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04448873Phase 4 · completed Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Kaposiform Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02110069Phase 2 · terminated A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Kaposiform Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04077515Phase 4 · completed Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Kaposiform Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03188068Phase 2 · completed Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Kaposiform Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532687Phase 2 · completed Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Adult Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01154452Phase 1/Phase 2 · completed Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma · condition mapped ONTOLOGY_EXACT · 21 trials mapped (9 active) | — | — | Adult Epithelioid Hemangioendothelioma | 1 | Observed | clinicaltrials | graph → |